Join Growin Stock Community!

葡萄王1707.TW Overview

TW StockBiotech. & Medical
(No presentation for 1707)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

葡萄王（1707）Overall Performance

葡萄王（1707）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

葡萄王（1707） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

葡萄王（1707）Key Information

葡萄王（1707）Profile

Grape King Bio Ltd produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan, China, and internationally. It operates through Multi-Level Marketing, Distributors, and Original Design Manufacturer/Original Equipment Manufacturer (ODM/OEM) segments. The company offers mushroom mycelium products, such as ganoderma lucidum, agaricus blazei, antrodia cinnamomea, cordyceps sinensis, and coriolus versicolor; probiotics, including enterococcus, bifidobacterium, lactobacillus, pediococcus, streptococcus, saccharomyces, and clostridium; and enzymes. It also provides OEM, ODM, formulation design, research and development, and raw material supply services. The company was founded in 1969 and is headquartered in Taoyuan City, Taiwan.

葡萄王（1707）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
8.24
PE Ratio (TTM)
14.75
Forward PE
14.33
PS Ratio (TTM)
1.73
PB Ratio
1.55
Price-to-FCF
9.86
METRIC
VALUE
vs. INDUSTRY
Gross Margin
75.66%
Net Margin
11.73%
Revenue Growth (YoY)
-5.40%
Profit Growth (YoY)
-8.32%
3-Year Revenue Growth
-3.75%
3-Year Profit Growth
-7.86%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
8.24
PE Ratio (TTM)
14.75
Forward PE
14.33
PS Ratio (TTM)
1.73
PB Ratio
1.55
Price-to-FCF
9.86
Gross Margin
75.66%
Net Margin
11.73%
Revenue Growth (YoY)
-5.40%
Profit Growth (YoY)
-8.32%
3-Year Revenue Growth
-3.75%
3-Year Profit Growth
-7.86%
default symbol

1707

葡萄王

121.50D

-1.23%

(-0.01)

  • When is 1707's latest earnings report released?

    The most recent financial report for 葡萄王 (1707) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 1707's short-term business performance and financial health. For the latest updates on 1707's earnings releases, visit this page regularly.

  • Where does 1707 fall in the P/E River chart?

    According to historical valuation range analysis, 葡萄王 (1707)'s current price-to-earnings (P/E) ratio is 8.32, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 1707?

    According to the latest financial report, 葡萄王 (1707) reported an Operating Profit of 542.09M with an Operating Margin of 22.33% this period, representing a decline of 27.47% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 1707's revenue growth?

    In the latest financial report, 葡萄王 (1707) announced revenue of 2.43B, with a Year-Over-Year growth rate of -16.26%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 1707 have?

    At the end of the period, 葡萄王 (1707) held Total Cash and Cash Equivalents of 3.15B, accounting for 0.22 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 1707 go with three margins increasing?

    In the latest report, 葡萄王 (1707) achieved the “three margins increasing” benchmark, with a gross margin of 73.63%%, operating margin of 22.33%%, and net margin of 19.01%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 1707's profit trajectory and future growth potential.

  • Is 1707's EPS continuing to grow?

    According to the past four quarterly reports, 葡萄王 (1707)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 2. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 1707?

    葡萄王 (1707)'s Free Cash Flow (FCF) for the period is 75.47M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 62.98% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.